Momentumtx

1 known investors

Momentum TX develops therapeutics targeting the aging process to treat age-related conditions of the central and peripheral nervous systems, with a focus on neurodegeneration. It uses in silico, in vitro, and in vivo methods and proteomics data to identify drug targets that restore protein configurations altered in the aged brain.

BiotechHealthtechLongevity